Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2012
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202826 Tetrahydropyrrolopyrimidinediones And Their Use In Therapy
08/09/2012US20120202824 Pyrazines as delta opioid receptor modulators
08/09/2012US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications
08/09/2012US20120202807 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202788 Azabenzothiazole compounds, compositions and methods of use
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202774 Acyloxy- and phosphoryloxy-butadiene-fe(co)3 complexes as enzyme-triggered co-releasing molecules
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202740 Scgb3a2 as a growth factor and anti-apoptotic agent
08/09/2012US20120201906 Novel medical uses for no and no donor compounds
08/09/2012US20120201887 Pharmaceutical Formulation
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201779 Antihistamine and antihistamine-like nasal application, products
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012DE102011010668A1 Wässrige pharmazeutische Zusammensetzung zur Prävention und/oder Therapie allergisch gereizter Nasenschleimhaut und dessen Verwendung Aqueous pharmaceutical composition for the prevention and / or therapy of allergic irritated nasal mucosa and the use thereof
08/09/2012CA2826193A1 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament, and method for the production thereof
08/09/2012CA2825576A1 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484382A1 Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483269A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases
08/08/2012EP2483253A2 Compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483252A2 Compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483251A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483233A2 Heteroatom containing substituted fatty acids
08/08/2012EP2482831A1 Compositions of botanical extracts and their use
08/08/2012EP2482811A2 Method and system for accessing patient data
08/08/2012EP2482810A2 Dosage regimen of an s1p receptor modulator
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2121693B1 8-oxoadenine derivatives as immuno-modulators
08/08/2012EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents
08/08/2012CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application
08/08/2012CN102626522A Polypeptide radioactive diagnosis and treatment medicament based on chemotactic factor receptor CXCR4 polypeptide antagonist
08/08/2012CN102626511A Drug composition used for relieving cough and eliminating phlegm
08/08/2012CN102626499A Traditional Chinese medicinal composition used as both food and medicine for treating porcine respiratory tract infection, and preparation method thereof
08/08/2012CN102626483A Application of Chinese medicinal composition to preparation of medicament for preventing and improving lung PM2.5 deposition
08/08/2012CN102626482A Application of Chinese medicinal composition to preparation of medicament for treating and improving lung PM2.5 deposition
08/08/2012CN102626473A Traditional Chinese medicine for treating traumatic injury, internal ulcer and external ulcer
08/08/2012CN102626464A Medicinal composition for treating chronic pharyngitis and preparation method and application thereof
08/08/2012CN102626439A Chinese medicinal preparation for preventing and treating cold and respiratory disease
08/08/2012CN102626392A Solid preparation of doxycycline ambroxol medicine compound
08/08/2012CN102626386A Bacilli calmette-gurin polysaccharide nucleic acid inhalation aerosol and preparation method and application thereof
08/08/2012CN102205013B Method for processing giant typhonium rhizome
08/08/2012CN102166298B Chronic pharyngitis preparation
08/08/2012CN102048974B Application of bagasse for preparing medicine for preventing and treating chronic obstructive pulmonary diseases
08/08/2012CN101803531B China cryptoporus sinensis and solid cultural method and application thereof
08/08/2012CN101243053B N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/08/2012CN101190306B Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/08/2012CN101056652B Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012CA2548666C Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2548654C Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/02/2012WO2012103398A2 Methods for treating obstructive sleep apnea
08/02/2012WO2012103116A1 Pulmonary administration of rifalazil and analogs thereof
08/02/2012WO2012103016A2 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
08/02/2012WO2012103015A2 Extended-release beta agonist/steroid transdermal patches and methods for using the same
08/02/2012WO2012102581A2 Composition for preventing or treating a respiratory disease containing a mixed herbal extract of cnidium officinale root and polygoni cuspidati root
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101197A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/02/2012WO2012100302A1 Combination vaccines
08/02/2012WO2012068209A3 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
08/02/2012WO2012053856A3 Respiratory syncytial virus vaccine composition and method for preparing same
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196875 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
08/02/2012US20120196867 Composition comprising a pde4 inhibitor and a pde5 inhibitor
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196857 Modulators of Muscarinic Receptors
08/02/2012US20120196854 Pharmaceutical composition comprising aromatic heterocyclic compound
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196819 Animal treatments
08/02/2012US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
08/02/2012US20120196790 Cyclic depsipeptides
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196749 Cyclosporin Derivatives
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195906 Method for diagnosing and treating emphysema
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES